AI eye exam could spot glaucoma in seconds

NCT ID NCT07668193

Not yet recruiting Diagnosis Sponsor: Fondazione G.B. Bietti, IRCCS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an artificial intelligence (AI) system called GlaukomAI that analyzes standard eye photos to detect glaucoma, a leading cause of blindness. Researchers will enroll 1,200 participants to see how accurately the AI identifies glaucoma compared to expert doctors. If it works well, this tool could make glaucoma screening faster and more accessible, helping people get treatment sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: GlaukomAI (Sens-vue GlaukomAI) - an AI-based diagnostic software
What this could lead to: If successful, this AI tool could help doctors find glaucoma earlier, potentially preventing blindness by speeding up referrals.
What could go wrong: This is an early validation study, not a treatment trial. The AI may not perform as well in real-world settings, and it only analyzes eye photos, not other tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA

More trials for these conditions

Other studies related to the condition(s) this trial covers.